New infusion aims to train immune system to handle gluten
Disease control
Completed
This study tested a new medicine called TPM502 in 28 adults with celiac disease. Participants received two infusions of TPM502 or a placebo, two weeks apart. The goal was to see if the treatment is safe and if it can help the body become more tolerant to gluten, potentially reduc…
Phase: PHASE2 • Sponsor: Topas Therapeutics GmbH • Aim: Disease control
Last updated May 14, 2026 12:05 UTC